semaglutide and cardiovascular outcomes in obesity align more closely with attained dose than achieved weight loss Semaglutide and Cardiovascular Outcomes in

Chung AE, Langdon RG

The Importance of Product Warnings Pharmaceutical companies bear a responsibility to disclose all known risks associated with their drugs

GLP-1 Agonists and Metabolic Health GLP-1 agonists regulate metabolic health, improving blood sugar levels and reducing risks of fatty liver, heart attacks, and strokes

If you are currently overweight or obese, you may be able to improve your overall health by losing just a small amount of weight

Malhotra, MD, a functional medicine doctor and weight-loss specialist in a suburb of Chicago, confirmed that she has seen myriad health improvements in patients taking GLP-1s particularly those with diabetes who were "very sick." "We observed that this sick population was doing better than the diabetics who were on other diabetes medicines," she shared with Fox News Digital, noting that she observed improvements in brain health, memory, heart health, circulation, and liver and kidney function